{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:13:56Z","timestamp":1754162036029,"version":"3.41.2"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Increasing evidence points to hyperhomocysteinemia as an independent risk factor for coronary artery disease in addition to traditional cardiovascular risks, but few have studied the association between hyperhomocysteinemia and total coronary artery occlusion (TCAO). To understand the risk factors for TCAO, we investigated the potential relationship between hyperhomocysteinemia and TCAO, and the interactions between cardiovascular risk factors and hyperhomocysteinemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 890 adult patients from Southwest China participated in this cross-sectional study between February 2018 and February 2021. TCAO was defined as complete occlusion of more than one of the 15 coronary segments. Hyperhomocysteinemia was defined as serum homocysteine levels \u226515\u2009\u03bcmol\/L. Multivariable logistic regression models were used to determine the relationship between hyperhomocysteinemia and TCAO. The relationship between homocysteine as a continuous variable and TCAO was also analyzed. Subgroup analyses by sex, age, weight, smoking, hypertension, diabetes, and dyslipidemia were done, and interactions between subgroup variables and hyperhomocysteinemia were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Individuals with hyperhomocysteinemia showed an increased risk for TCAO. The adjusted odds ratio for TCAO in individuals with hyperhomocysteinemia was 1.74 (95% confidence interval, 1.28\u20132.36). When analyzed as a continuous variable, homocysteine was associated with an increased risk for TCAO. Subgroup analysis showed that the association between hyperhomocysteinemia and TCAO was statistically significant in men, elderly, overweight, smokers, and non-diabetic people. Interaction analysis showed no significant interactions between hyperhomocysteinemia and group variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In Southwest China, hyperhomocysteinemia was significantly associated with TCAO. This association was particularly significant in men, elderly, overweight, smokers, and non-diabetic people.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001217","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T14:16:09Z","timestamp":1673532969000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between hyperhomocysteinemia and total coronary artery occlusion: a cross-sectional study from Southwest China"],"prefix":"10.1097","volume":"34","author":[{"given":"Kaiyong","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Dongcheng District, Beijing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical Laboratory Center, Guangyuan Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xv","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Guangyuan Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Xv","sequence":"additional","affiliation":[{"name":"Sterilization Supply Center, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangyuan Central Hospital, Lizhou District, Guangyuan, Sichuan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"518","DOI":"10.46234\/ccdcw2022.026","article-title":"Case fatality rate of patients with acute myocardial infarction in 253 Chest Pain Centers - China, 2019-2020.","volume":"4","author":"Long","year":"2022","journal-title":"China CDC Wkly"},{"key":"R2-20250729","first-page":"401","article-title":"Relationship between infarct artery location, acute total coronary occlusion, and mortality in STEMI and NSTEMI patients.","volume":"127","author":"Karwowski","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/medicina57111196","article-title":"Total occlusion of the infarct-related artery in non-ST-elevation myocardial infarction (NSTEMI)-how can we identify these patients?","volume":"57","author":"Morawska","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ahj.2009.01.004","article-title":"Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.","volume":"157","author":"Wang","year":"2009","journal-title":"Am Heart J"},{"key":"R5-20250729","first-page":"9","article-title":"Non-ST elevation myocardial infarction related to total coronary artery occlusion - prevalence and patient characteristics.","volume":"11","author":"Roleder","year":"2015","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCULATIONAHA.119.039797","article-title":"Guiding principles for chronic total occlusion percutaneous coronary intervention.","volume":"140","author":"Brilakis","year":"2019","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4244\/EIJ-D-18-00826","article-title":"Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club.","volume":"15","author":"Galassi","year":"2019","journal-title":"EuroIntervention"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3390\/ijms17101733","article-title":"The molecular and cellular effect of homocysteine metabolism imbalance on human health.","volume":"17","author":"\u0160kovierov\u00e1","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R9-20250729","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol"},{"key":"R10-20250729","first-page":"223","article-title":"Influence of serum homocysteine level on coronary atherosclerosis in Japanese.","volume":"43","author":"Kobori","year":"2004","journal-title":"J Cardiol"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/000331970405500507","article-title":"Association of serum total homocysteine with the extent of ischemic heart disease in a Mediterranean cohort.","volume":"55","author":"Vrentzos","year":"2004","journal-title":"Angiology"},{"issue":"Suppl 1","key":"R12-20250729","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0049-3848(01)00295-X","article-title":"Homocysteine plasma levels in young patients with coronary artery disease. Relation to history of acute myocardial infarction and anatomical extent of disease.","volume":"103","author":"Nikfardjam","year":"2001","journal-title":"Thromb Res"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1093\/eurheartj\/ehaa368","article-title":"Severe vasospastic angina causing total coronary occlusion.","volume":"41","author":"Pol","year":"2020","journal-title":"Eur Heart J"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0939-4753(03)80005-4","article-title":"Biochemical markers of vasospastic coronary artery disease.","volume":"13","author":"Yamaguchi","year":"2003","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1253\/circj.71.266","article-title":"Plasma homocysteine concentration in patients with poor or good coronary collaterals.","volume":"71","author":"Sayar","year":"2007","journal-title":"Circ J"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/2047487319894679","article-title":"No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: a Mendelian randomization study.","volume":"28","author":"Miao","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12872-018-0774-8","article-title":"Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","article-title":"Homocysteine and vascular disease.","volume":"354","author":"Hankey","year":"1999","journal-title":"Lancet"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2015.06.009","article-title":"Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: a mechanistic and clinical perspective.","volume":"78","author":"Santilli","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0140-6736(64)92852-1","article-title":"Homocystinuria, thrombosis, and the blood-plateleTS.","volume":"1","author":"McDonald","year":"1964","journal-title":"Lancet"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/eurheartj\/ehn515","article-title":"Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.","volume":"30","author":"Antoniades","year":"2009","journal-title":"Eur Heart J"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.95.7.1777","article-title":"Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1089\/ars.2010.3721","article-title":"Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.","volume":"15","author":"Steed","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/157016110790226552","article-title":"Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms.","volume":"8","author":"Maldonado","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"R26-20250729","first-page":"3203","article-title":"Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology.","volume":"119","author":"Loscalzo","year":"2009","journal-title":"J Clin Invest"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease.","volume":"14","author":"Ganguly","year":"2015","journal-title":"Nutr J"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2005.01.001","article-title":"Plasma homocysteine predicts progression of atherosclerosis.","volume":"181","author":"Rasouli","year":"2005","journal-title":"Atherosclerosis"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes (2).","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yjmcc.2019.11.145","article-title":"Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b\/SP1 pathway.","volume":"138","author":"Guo","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2018.10.060","article-title":"Homocysteine accelerates atherosclerosis via inhibiting LXR\u03b1-mediated ABCA1\/ABCG1-dependent cholesterol efflux from macrophages.","volume":"214","author":"Jin","year":"2018","journal-title":"Life Sci"},{"key":"R32-20250729","first-page":"74","article-title":"SNF5 promotes IL-1\u03b2 expression via H3K4me1 in atherosclerosis induced by homocysteine.","volume":"135","author":"Xie","year":"1059","journal-title":"Int J Biochem Cell Biol"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cca.2016.02.026","article-title":"Aberrant DNA methylation in the pathogenesis of atherosclerosis.","volume":"456","author":"Hai","year":"2016","journal-title":"Clin Chim Acta"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mvr.2018.05.003","article-title":"Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells.","volume":"120","author":"Wei","year":"2018","journal-title":"Microvasc Res"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.numecd.2018.09.003","article-title":"Gender differences in homocysteine concentrations, a population-based cross-sectional study.","volume":"29","author":"Cohen","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0008-6363(01)00462-X","article-title":"Estrogen and homocysteine.","volume":"53","author":"Dimitrova","year":"2002","journal-title":"Cardiovasc Res"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9149(97)00643-7","article-title":"Association between plasma homocysteine and coronary artery disease in older persons.","volume":"80","author":"Aronow","year":"1997","journal-title":"Am J Cardiol"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1017\/S000711451200520X","article-title":"Plasma total homocysteine status of vegetarians compared with omnivores: a systematic review and meta-analysis.","volume":"109","author":"Obersby","year":"2013","journal-title":"Br J Nutr"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.arr.2018.10.010","article-title":"Homocysteine and age-associated disorders.","volume":"49","author":"Ostrakhovitch","year":"2019","journal-title":"Ageing Res Rev"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1995.03530190040032","article-title":"Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study.","volume":"274","author":"Nyg\u00e5rd","year":"1995","journal-title":"JAMA"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(92)90246-D","article-title":"Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease.","volume":"94","author":"Nordstr\u00f6m","year":"1992","journal-title":"Atherosclerosis"},{"key":"R42-20250729","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.freeradbiomed.2017.10.389","article-title":"Nitration-mediated deficiency of cystathionine \u03b2-synthase activity accelerates the progression of hyperhomocysteinemia.","volume":"113","author":"Wang","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"R43-20250729","first-page":"322","article-title":"Comparison of novel coronary artery disease risk factors between obese and normal adolescent.","volume":"40","author":"Kouzehgaran","year":"2015","journal-title":"Iran J Med Sci"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/000331970305400207","article-title":"Identifying risk factors in a mostly overweight patient population with coronary artery disease.","volume":"54","author":"Yolo\u011flu","year":"2003","journal-title":"Angiology"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12872-021-02302-0","article-title":"Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults \u2264 35 years of age: a hospital-based observational study.","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1053\/euhj.2002.3172","article-title":"Smoking and plasma homocysteine.","volume":"23","author":"O\u2019Callaghan","year":"2002","journal-title":"Eur Heart J"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"15812","DOI":"10.1073\/pnas.1309049110","article-title":"Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia.","volume":"110","author":"d\u2019Emmanuele di Villa Bianca","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000441478","article-title":"Impact of diabetes on homocysteine levels and its relationship with coronary artery disease: a single-centre cohort study.","volume":"68","author":"Schaffer","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00592-020-01608-3","article-title":"The impact of homocysteine on the risk of coronary artery diseases in individuals with diabetes: a Mendelian randomization study.","volume":"58","author":"Xu","year":"2021","journal-title":"Acta Diabetol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:03:58Z","timestamp":1753812238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001217","relation":{},"ISSN":["0954-6928"],"issn-type":[{"type":"print","value":"0954-6928"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}